Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Takeda gains expanded access rights to Vero cell technology platform

Aug. 28, 2015

Allele Biotechnology launches new nano-antibody research tools

Aug. 28, 2015

Allied-Bristol licenses antibody-recruiting molecule technology from Yale

Aug. 27, 2015

Tissue Therapies partners with the Queensland University of Technology on research

Aug. 27, 2015

Hospira and Cerner expand technology agreement

Aug. 26, 2015

Covance enters into agreement with leading pharmaceutical company for clinical trial monitoring

Aug. 26, 2015

Roche acquires nucleic acid purification assets from Lumora

Aug. 25, 2015

La Jolla Pharmaceutical and Vanderbilt University form agreement for BMP type-I receptor inhibitors

Aug. 20, 2015

HiFiBiO achieves milestone in Pfizer antibody research collaboration

Aug. 14, 2015

Midatech and Ophthotech sign agreement to explore sustained delivery formulations

Aug. 13, 2015

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...